BOSTON SCIENTIFIC CORP — Director's Dealing 2023

Oct 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2023-10-16

Reporting Person: Carruthers Wendy (EVP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-16	Common Stock	M	3448.0000	$16.3100	Acquired	60506.0000	Direct
2023-10-16	Common Stock	M	2960.0000	$13.0800	Acquired	63466.0000	Direct
2023-10-16	Common Stock	S	11671.0000	$49.7869	Disposed	51795.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-16	Stock Option (Right to Buy)	$16.3100	M	3448.0000	Disposed	2025-02-23	Common Stock (3448.0000)	Direct
2023-10-16	Stock Option (Right to Buy)	$13.0800	M	2960.0000	Disposed	2024-02-24	Common Stock (2960.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 9, 2023, intended to comply with the prior version of Rule 10b5-1(c).

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $49.52 to $50.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.